Author

Craig W. Hendrix

Johns Hopkins UniversityORCID 0000-0002-5696-8665Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Ben OrsburniD· 1 shared Colten D. EberhardiD· 1 shared Cory J. WhiteiD· 1 shared Dionna W. WilliamsiD· 1 shared Edward J. FuchsiD· 1 shared Ekta GuptaiD· 1 shared H. Y. KimiD· 1 shared Hannah N. WilkinsiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Ben OrsburnORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Aging, HIV Status, and Sex Differentially Influence Antiretroviral Therapy Disposition Pathways in Rectosigmoid Tissue and Peripheral Blood Mononuclear Cells

Hannah N. Wilkins, Cory J. White, Ruohui Zheng, Labib A. Mamun, Colten D. Eberhard, Edward J. Fuchs, Jennifer Hoffmann, Ekta Gupta, Ben Orsburn, Craig W. Hendrix, Namandjé N. Bumpus, Dionna W. Williams

This study identifies how aging and HIV status differentially affect antiretroviral therapy disposition pathways in rectosigmoid tissue and PBMC, with aging causing broader changes in drug-related proteins.

bioRxiv · Nov 6, 2026 · PreprintPharmacology & Toxicology

Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subdermal implant

H. Y. Kim, Lanxin Zhang, Craig W. Hendrix, Jessica Elizabeth Haberer, Max von Kleist

This paper models the efficacy and toxicity of islatravir as oral and subdermal PrEP, finding implants offer safer efficacy while oral dosing has toxicity risks.

bioRxiv · Apr 15, 2024 · PreprintSystems Biology